Management ChangeMay 18, 2026, 06:46 AM
Wyndham CEO Diagnosed with Multiple Myeloma; CAO to Depart
AI Summary
Wyndham Hotels & Resorts, Inc. announced that President and CEO Geoff Ballotti has been diagnosed with Multiple Myeloma but intends to continue working largely as normal, with a favorable prognosis. Additionally, Chief Accounting Officer Nicola Rossi will depart the company on July 31, 2026, and Christopher Androski, current Senior Vice President and Controller, will succeed him. The company also held its 2026 Annual Meeting of Stockholders, where all nine Director nominees were elected, executive compensation was approved on an advisory basis, Deloitte & Touche LLP was ratified as the independent auditor, and a stockholder proposal for written consent was approved.
Key Highlights
- CEO Geoff Ballotti disclosed diagnosis of Multiple Myeloma, plans to continue working largely as normal.
- Chief Accounting Officer Nicola Rossi will depart the company on July 31, 2026.
- Christopher Androski, SVP and Controller, will assume the role of Chief Accounting Officer effective July 31, 2026.
- Stockholders elected nine Director nominees to serve until the 2027 annual meeting.
- Stockholders approved, on an advisory basis, the compensation of named executive officers.
- Stockholders ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026.
- Stockholders approved a proposal regarding the ability to act by written consent.
Price Impact
More from WH